Clinical Trials Browser

Phase 1/2 × decitabine and cedazuridine drug combination × Dermatologic × Clear all

NCT07472322 2026-03-16

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Phase 1/2 Not yet recruiting

Carcinoma, Merkel Cell

NCT05089370 2025-12-08

Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

Phase 1/2 Active not recruiting

Melanoma